Danaher downgraded to Neutral from Buy at Goldman Sachs

Goldman Sachs downgraded Danaher to Neutral from Buy with a price target of $205, down from $215. At the stock’s current valuation, there are more attractive opportunities in the tools space, the analyst tells investors in a research note. The firm says Danaher has been one of its top picks during 2023 and has been the one of best performing names in the sector year-to-date, driven by a recovery in its diagnostics business, focus on higher growth end markets, and perception of higher quality which became attractive in a more volatile environment.